Latest Articles
Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception.
Endometriosis is increasingly recognized as a chronic systemic disorder extending beyond the classical estrogen-dependent paradigm, integrating metabolic, immune, fibrotic, and nociceptive pathways that sustain lesion persistence and refractory pelvic pain. …
Published: June 24, 2026, midnight
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times
Published: May 22, 2026, 4:29 a.m.
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk - 2 Minute Medicine
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 …
Published: Feb. 11, 2026, 6:31 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - Bioengineer.org
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on Bioengineer.org
Published: Feb. 10, 2026, 6:37 p.m.
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on - BIOENGINEER.ORG
GLP-1 Receptor Agonists Combined with Progestins and Their Impact on BIOENGINEER.ORG
Published: Feb. 10, 2026, 6:37 p.m.
Link copied to clipboard!